Effects of the β -blockers on cardiac protection and hemodynamics in patients with septic shock: A prospective study

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue

Volumn 26, Issue 10, 2014, Pages 714-717

  Yang, Shengqiang ^a   Liu, Zhen ^a   Yang, Wenbao ^a   Zhang, Guizhen ^a   Hou, Baojun ^a   Liu, Jihua ^a   Shi, Qibiao ^a  

^a JINING MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac protection; Hemodynamics; Septic shock; blockers

Indexed keywords

ESMOLOL; LACTIC ACID; TROPONIN I;

ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLOBAL ENDIDIASTOLIC VOLUME INDEX; HEART INDEX; HEART MUSCLE INJURY; HEART PROTECTION; HEART RATE; HEART STROKE VOLUME; HEART VOLUME; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; MEAN ARTERIAL PRESSURE; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SYSTEMIC VASCULAR RESISTANCE; TISSUE METABOLISM; VENOUS OXYGEN TENSION;

EID: 84929515486     PISSN: 20954352     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.2095-4352.2014.10.007     Document Type: Article

References (16)

1. Du B, An Y, Kang Y, et al. Characteristics of critically ill patients in ICUs in mainland China [J]. Crit Care Med, 2013, 41 (1): 84-92.
2. Hunter JD, Doddi M. Sepsis and the heart [J]. Br J Anaesth, 2010, 104 (1): 3-11.
3. Hjalmarson A. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period [J]. Am J Cardiol, 1997, 80 (9B): 35J-39J.
4. Poldermans D, Bax JJ, Boersma E, et al. Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA) [J]. Eur J Anaesthesiol, 2010, 27 (2): 92-137.
5. Aboab J, Sebille V, Jourdain M, et al. Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock [J]. Intensive Care Med, 2011, 37 (8): 1344-1351.
6. Silasi-Mansat R, Zhu H, Popescu NI, et al. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis [J]. Blood, 2010, 116 (6): 1002-1010.
7. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM / ESICM / ACCP/ATS/SIS International Sepsis Definitions Conference [J]. Crit Care Med, 2003, 31 (4): 1250-1256.
8. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 [J]. Crit Care Med, 2008, 36 (1): 296-327.
9. Waisbren BA. Bacteremia due to gram-negative bacilli other than the Salmonella;a clinical and therapeutic study [J]. AMA Arch Intern Med, 1951, 88 (4): 467-488.
10. Flierl MA, Rittirsch D, Huber-Lang MS, et al. Molecular events in the cardiomyopathy of sepsis [J]. Mol Med, 2008, 14 (5-6): 327-336.
11. Rudiger A. Beta-block the septic hear[J]. Crit Care Med, 2010, 38 (10): S608-612.
12. Werdan K, Müller U, Reithmann C, et al. Mechanisms in acute septic cardiomyopathy: evidence from isolated myocytes [J]. Basic Res Cardiol, 1991, 86 (5): 411-421.
13. Joulin O, Marechaux S, Hassoun S, et al. Cardiac force-frequency relationship and frequency-dependent acceleration of relaxation are impaired in LPS-treated rats [J]. Crit Care, 2009, 13 (1): R14.
14. Werdan K, Oelke A, Hettwer S, et al. Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications [J]. Clin Res Cardiol, 2011, 100 (8): 661-668.
15. Lyon AR, Rees PS, Prasad S, et al. Stress (Takotsubo)cardiomyopathy- a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning [J]. Nat Clin Pract Cardiovasc Med, 2008, 5 (1): 22-29.
16. Balik M, Rulisek J, Leden P, et al. Is cardioprotective betablockade feasible in severe sepsis? A pilot study [J]. Int Care Med, 2011, 37 (suppl 1): s89.